These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38084790)

  • 21. The Mouse Papillomavirus Infection Model.
    Hu J; Cladel NM; Budgeon LR; Balogh KK; Christensen ND
    Viruses; 2017 Aug; 9(9):. PubMed ID: 28867783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell-mediated antitumor immune response eliminates skin tumors induced by mouse papillomavirus, MmuPV1.
    Joh J; Chilton PM; Wilcher SA; Zahin M; Park J; Proctor ML; Ghim SJ; Jenson AB
    Exp Mol Pathol; 2017 Oct; 103(2):181-190. PubMed ID: 28939161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.
    Matinhira N; Soko ND; Bandason T; Jenson RG; Dzongodza T; von Buchwald C; Chidziva C
    Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():147-152. PubMed ID: 30554686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse papillomavirus type 1 (MmuPV1) DNA is frequently integrated in benign tumors by microhomology-mediated end-joining.
    Yu L; Majerciak V; Xue XY; Uberoi A; Lobanov A; Chen X; Cam M; Hughes SH; Lambert PF; Zheng ZM
    PLoS Pathog; 2021 Aug; 17(8):e1009812. PubMed ID: 34343212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel lineage-tracing mouse model for studying early MmuPV1 infections.
    Yilmaz V; Louca P; Potamiti L; Panayiotidis M; Strati K
    Elife; 2022 May; 11():. PubMed ID: 35533001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mus musculus papillomavirus 1 is a key driver of skin cancer development upon immunosuppression.
    Dorfer S; Strasser K; Schröckenfuchs G; Bonelli M; Bauer W; Kittler H; Cataisson C; Fischer MB; Lichtenberger BM; Handisurya A
    Am J Transplant; 2021 Feb; 21(2):525-539. PubMed ID: 33063442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy.
    Cladel NM; Budgeon LR; Cooper TK; Balogh KK; Christensen ND; Myers R; Majerciak V; Gotte D; Zheng ZM; Hu J
    J Gen Virol; 2017 Oct; 98(10):2520-2529. PubMed ID: 28942760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Topically Administered Dihydroartemisinin in Treating Papillomavirus-Induced Anogenital Dysplasia in Preclinical Mouse Models.
    Gunder LC; Blaine-Sauer S; Johnson HR; Shin MK; Auyeung AS; Zhang W; Leverson GE; Ward-Shaw ET; King RE; McGregor SM; Matkowskyj KA; Lambert PF; Carchman EH
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infectivity of murine papillomavirus in the surgical byproducts of treated tail warts.
    Best SR; Esquivel D; Mellinger-Pilgrim R; Roden RBS; Pitman MJ
    Laryngoscope; 2020 Mar; 130(3):712-717. PubMed ID: 31041820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent oral human papilloma virus infection in patients with recurrent respiratory papillomatosis: a preliminary study.
    Born H; Ruiz R; Verma A; Taliercio S; Achlatis S; Pitman M; Gandonu S; Bing R; Amin MR; Branski RC
    Laryngoscope; 2014 Dec; 124(12):2785-90. PubMed ID: 25059492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and clinical implications of low-risk human papillomavirus among patients with recurrent respiratory papillomatosis in Rio de Janeiro, Brazil.
    Figueiredo MC; Justino MC; Delmonico L; Silvestre RT; de Castro TL; Dos Santos Moreira A; Macedo JMB; da Costa Carvalho MDG; Scherrer L; de Medeiros Lima DJM; Alves G; Ornellas MH
    Auris Nasus Larynx; 2019 Aug; 46(4):570-575. PubMed ID: 30581074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevalence of human papillomavirus infection in squamous cell carcinoma of the oral cavity, oropharynx and larynx].
    Villagómez-Ortíz VJ; Paz-Delgadillo DE; Marino-Martínez I; Ceseñas-Falcón LÁ; Sandoval-de la Fuente A; Reyes-Escobedo A
    Cir Cir; 2016; 84(5):363-8. PubMed ID: 27032466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of E6 in Maintaining the Basal Cell Reservoir during Productive Papillomavirus Infection.
    Saunders-Wood T; Egawa N; Zheng K; Giaretta A; Griffin HM; Doorbar J
    J Virol; 2022 Mar; 96(5):e0118121. PubMed ID: 35019722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.
    Scagnolari C; Cannella F; Pierangeli A; Mellinger Pilgrim R; Antonelli G; Rowley D; Wong M; Best S; Xing D; Roden RBS; Viscidi R
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32295905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Cellular MEK/ERK Signaling Suppresses Murine Papillomavirus Type 1 Replicative Activities and Promotes Tumor Regression.
    Luna AJ; Young JM; Sterk RT; Bondu V; Schultz FA; Kusewitt DF; Kang H; Ozbun MA
    bioRxiv; 2023 Apr; ():. PubMed ID: 36993217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human papillomavirus 16 E5 gene potentiates MmuPV1-Dependent pathogenesis.
    Torres AD; Spurgeon ME; Bilger A; Blaine-Sauer S; Uberoi A; Buehler D; McGregor SM; Ward-Shaw E; Lambert PF
    Virology; 2020 Feb; 541():1-12. PubMed ID: 31826841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laryngeal distribution of recurrent respiratory papillomatosis in a previously untreated cohort.
    Benedict PA; Ruiz R; Yoo M; Verma A; Ahmed OH; Wang B; Dion GR; Voigt A; Merati A; Rosen CA; Amin MR; Branski RC
    Laryngoscope; 2018 Jan; 128(1):138-143. PubMed ID: 28714564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse papillomavirus MmuPV1 infects oral mucosa and preferentially targets the base of the tongue.
    Cladel NM; Budgeon LR; Balogh KK; Cooper TK; Hu J; Christensen ND
    Virology; 2016 Jan; 488():73-80. PubMed ID: 26609937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Ultraviolet Radiation in Papillomavirus-Induced Disease.
    Uberoi A; Yoshida S; Frazer IH; Pitot HC; Lambert PF
    PLoS Pathog; 2016 May; 12(5):e1005664. PubMed ID: 27244228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune Responses in Oral Papillomavirus Clearance in the MmuPV1 Mouse Model.
    Brendle SA; Li JJ; Walter V; Schell TD; Kozak M; Balogh KK; Lu S; Christensen ND; Zhu Y; El-Bayoumy K; Hu J
    Pathogens; 2023 Dec; 12(12):. PubMed ID: 38133335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.